The PIK3CA/AKT pathway drives therapy resistance in rhabdomyosarcoma

Journal:

Nature Communications

Published:

2025-12-10

DOI:

10.1038/s41467-025-66632-9

Affiliations:

5

Authors:

16

Go to article

Institutions	Authors	Share
Massachusetts General Hospital (MGH), United States of America (USA)	11.166667 11.166667	0.70
Harvard Stem Cell Institute (HSCI), United States of America (USA)	3.750000	0.23
Broad Institute of MIT and Harvard, United States of America (USA)	0.583333	0.04
Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore	0.500000	0.03

Interested in Oncology and Carcinogenesis?